221 related articles for article (PubMed ID: 22234329)
1. Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs.
Billman GE; Gögelein H; Ruetten H; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):373-84. PubMed ID: 22234329
[TBL] [Abstract][Full Text] [Related]
2. Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats.
Goegelein H; Gautier P; Roccon A; O'Connor S; Ruetten H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):231-44. PubMed ID: 21766160
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
Shinagawa K; Shiroshita-Takeshita A; Schram G; Nattel S
Circulation; 2003 Mar; 107(10):1440-6. PubMed ID: 12642367
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
Wirth KJ; Knobloch K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):166-74. PubMed ID: 11218069
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogs.
Varga RS; Hornyik T; Husti Z; Kohajda Z; Krajsovszky G; Nagy N; Jost N; Virág L; Tálosi L; Mátyus P; Varró A; Baczkó I
Can J Physiol Pharmacol; 2021 Jan; 99(1):89-101. PubMed ID: 32970956
[TBL] [Abstract][Full Text] [Related]
6. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Finance O; Manning A; Chatelain P
J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
[TBL] [Abstract][Full Text] [Related]
8. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
9. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity.
Bonatti R; Silva AF; Batatinha JA; Sobrado LF; Machado AD; Varone BB; Nearing BD; Belardinelli L; Verrier RL
Heart Rhythm; 2014 Oct; 11(10):1827-35. PubMed ID: 24953379
[TBL] [Abstract][Full Text] [Related]
10. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.
Burashnikov A; Belardinelli L; Antzelevitch C
Heart Rhythm; 2010 Sep; 7(9):1273-9. PubMed ID: 20478403
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs.
Nagasawa Y; Chen J; Hashimoto K
J Pharmacol Sci; 2005 Mar; 97(3):393-9. PubMed ID: 15764841
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L
Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
[TBL] [Abstract][Full Text] [Related]
13. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA
Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation.
Saengklub N; Limprasutr V; Sawangkoon S; Hamlin RL; Kijtawornrat A
Exp Anim; 2017 Aug; 66(3):251-258. PubMed ID: 28381818
[TBL] [Abstract][Full Text] [Related]
15. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias.
Gautier P; Serre M; Cosnier-Pucheu S; Djandjighian L; Roccon A; Herbert JM; Nisato D
J Cardiovasc Pharmacol; 2005 Feb; 45(2):125-35. PubMed ID: 15654261
[TBL] [Abstract][Full Text] [Related]
17. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
Burashnikov A; Di Diego JM; Sicouri S; Ferreiro M; Carlsson L; Antzelevitch C
Heart Rhythm; 2008 Dec; 5(12):1735-42. PubMed ID: 19084813
[TBL] [Abstract][Full Text] [Related]
18. Hybrid therapy of atrial fibrillation.
Santini M; Pignalberi C; Ricci R; Calò L
Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
Singh BN; Mody FV; Lopez B; Sarma JS
Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic effect of the Ca
Kirchhoff JE; Diness JG; Abildgaard L; Sheykhzade M; Grunnet M; Jespersen T
Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
